Ligand Pharmaceuticals, Inc. (LGND)
285.60
-4.14
(-1.43%)
USD |
NASDAQ |
Sep 04, 16:00
285.75
+0.15
(+0.05%)
Pre-Market: 20:00
Ligand Pharmaceuticals Cash and Short Term Investments (Annual) : 733.52M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 733.52M |
| December 31, 2024 | 256.16M |
| December 31, 2023 | 170.31M |
| December 31, 2022 | 211.87M |
| December 31, 2021 | 341.11M |
| December 31, 2020 | 411.53M |
| December 31, 2019 | 1.071B |
| December 31, 2018 | 767.19M |
| December 31, 2017 | 201.66M |
| December 31, 2016 | 141.05M |
| December 31, 2015 | 200.22M |
| December 31, 2014 | 167.34M |
| December 31, 2013 | 15.98M |
| December 31, 2012 | 12.38M |
| December 31, 2011 | 17.04M |
| December 31, 2010 | 22.70M |
| December 31, 2009 | 53.23M |
| Date | Value |
|---|---|
| December 31, 2008 | 80.67M |
| December 31, 2007 | 94.41M |
| December 31, 2006 | 210.66M |
| December 31, 2005 | 86.93M |
| December 31, 2004 | 112.49M |
| December 31, 2003 | 99.03M |
| December 31, 2002 | 64.25M |
| December 31, 2001 | 37.69M |
| December 31, 2000 | 23.66M |
| December 31, 1999 | 47.16M |
| December 31, 1998 | 69.97M |
| December 31, 1997 | 83.23M |
| December 31, 1996 | 80.65M |
| December 31, 1995 | 70.14M |
| December 31, 1994 | 38.40M |
| December 31, 1993 | 42.35M |
| December 31, 1992 | 55.60M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Johnson & Johnson | 20.10B |
| Eli Lilly & Co. | 7.268B |
| Merck & Co., Inc. | 14.69B |
| Zevra Therapeutics, Inc. | 191.01M |
| Liquidia Corp. | 190.68M |